Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

 in 2023, where she produces written content covering multiple disease states.

She has a BA in journalism from Seton Hall University. You can connect with Brooke on 

Articles

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of shortages lasting over 2 years due to ongoing supply and manufacturing issues.

5 Essential Drugs Currently Facing Shortages 

The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.


PAH Treatment Outcomes Similar Regardless of Diagnosis Time

Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.

She has a BA in English language and literature from Rutgers University. You can connect with Julia on 

As bird flu cases spread in both livestock and agriculture workers, the Department of Agriculture is taking steps to stop the spread of the virus.

Bird Flu Cases Spark More Preventive Measures to Curb Spread

Cameron Santoro is an associate editor for 

), AJMC.com, and The Center for Biosimilars

The COVID-19 pandemic required an evolution of traditional nursing practices,  but the unpredictability led to increased stress, burnout, and job dissatisfaction. 

COVID-19 Leaves Lasting Impact on Nursing Practices and Job Satisfaction

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Hematology

Hepatology

Immunology

Infectious Disease

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

Employing Effective Multidisciplinary Care to Reduce the Burden of Myelodysplastic Syndrome 

Video Series

Key opinion leaders discuss the process of adapting MDS treatment strategies for optimal impact of care.

Adapting MDS Treatment Approach 

Videos

A panel of medical experts discuss the significance of collaborative care and key considerations in the treatment of myelodysplastic syndrome (MDS).

Ryan Haumschild, PharmD, MS, MBA, CPEL, opens the discussion by defining the MDS disease state. 

Myelodysplastic Syndrome (MDS) Overview 

An expert perspective on the variety of MDS subtypes is provided. 

Distinguishing Between Different MDS Subtypes 

Key opinion leaders discuss how patient quality of life is impacted by MDS treatment-associated challenges.

MDS-Related Complications Impacting Patient Quality of Life

Financial considerations in MDS treatment are discussed.

Economic Implications of MDS Management

Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome.

Examining Treatment Algorithms for MDS 

Considerations for growth factor and stem cell transplant for patients with MDS is discussed. 

Growth Factor and Stem Cell Transplant Candidacy in MDS

A panel of experts discusses how novel agents are impacting the treatment landscape for patients diagnosed with MDS. 

Novel Agents Contributing to Evolving MDS Therapy Strategies 

Treatment compliance impacted by oral versus IV therapy is evaluated. 

Benefits of Oral Therapies In MDS Treatment Adherence 

Novel therapies in MDS treatment are evaluated by a panel of experts led by Dr Haumschild.

Novel Therapy Impact on Patient Quality of Life

Experts discuss how collaborative care drives optimal MDS treatment.

Multidisciplinary Care Driving Effective MDS Treatment

The panelists highlight key takeaways for payors involved in MDS treatment. 

Payor Considerations In MDS Management

Potential issues associated with insurance coverage and ways to navigate these challenges are discussed by medical experts.

Navigating Insurance-Related Challenges Associated With MDS Treatment

The panelists provide their final takeaways from the discussion surrounding treatment of MDS.

Key Considerations Surrounding MDS Treatment

Adapting MDS Treatment Approach

EP: 1.Myelodysplastic Syndrome (MDS) Overview

EP: 2.Distinguishing Between Different MDS Subtypes

EP: 3.MDS-Related Complications Impacting Patient Quality of Life

EP: 4.Economic Implications of MDS Management

EP: 5.Examining Treatment Algorithms for MDS

EP: 6.Growth Factor and Stem Cell Transplant Candidacy in MDS

EP: 7.Novel Agents Contributing to Evolving MDS Therapy Strategies

EP: 8.Benefits of Oral Therapies In MDS Treatment Adherence

EP: 9.Adapting MDS Treatment Approach

EP: 10.Novel Therapy Impact on Patient Quality of Life

EP: 11.Multidisciplinary Care Driving Effective MDS Treatment

EP: 12.Payor Considerations In MDS Management

EP: 13.Navigating Insurance-Related Challenges Associated With MDS Treatment

EP: 14.Key Considerations Surrounding MDS Treatment